C

    CPRX (CPRX)

    Official site

    BIOTECHNOLOGY

    $31.49
    +0.00 (+0.00%)

    Last updated: Jul 16, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    77%(30/39)
    Avg Surprise
    +19.39%
    Streak
    10 Q

    Upcoming Estimates

    Jun 30, 2026
    EPS Consensus$0.74
    Range$0.74 - $0.74
    1 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$0.68-8.3%
    60d ago$0.68-8.3%
    30d ago$0.69-5.9%
    7d ago$0.69-5.9%
    Current$0.74
    Revenue Consensus
    $155M
    Range$152M - $158M
    4 analysts
    Sep 30, 2026
    EPS Consensus$0.82
    Range$0.82 - $0.82
    1 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$0.72-12.6%
    60d ago$0.72-12.6%
    30d ago$0.73-10.8%
    7d ago$0.73-10.8%
    Current$0.82
    Revenue Consensus
    $162M
    Range$158M - $165M
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.98---
    Sep 26EST
    		-$0.82---
    Jun 26EST
    		-$0.74---
    Mar 26
    		$0.79$0.64+23.44%Beat+75.6%
    Dec 25
    		$0.68$0.30+128.19%Beat+54.5%
    Sep 25
    		$0.64$0.48+33.33%Beat+12.3%
    Jun 25
    		$0.68$0.54+25.93%Beat+21.4%
    Mar 25
    		$0.45$0.34+32.35%Beat+18.4%
    Dec 24
    		$0.44$0.32+37.50%Beat+41.9%
    Sep 24
    		$0.57$0.51+11.76%Beat+296.6%
    Jun 24
    		$0.56$0.43+30.23%Beat+69.7%
    Mar 24
    		$0.38$0.30+26.67%Beat+46.2%
    Dec 23
    		$0.31$0.27+14.81%Beat+40.9%
    Sep 23
    		$-0.29$0.45-164.44%Miss-220.8%
    Jun 23
    		$0.33$0.41-19.51%Miss+65.0%
    Mar 23
    		$0.26$0.31-16.13%Miss+116.7%
    Dec 22
    		$0.22$0.21+4.76%Beat+144.4%
    Sep 22
    		$0.24$0.19+26.32%Beat+140.0%
    Jun 22
    		$0.20$0.17+17.65%Beat+81.8%
    Mar 22
    		$0.12$0.14-14.29%Miss+71.4%
    Dec 21
    		$0.09$0.12-25.00%Miss-18.2%
    Sep 21
    		$0.10$0.12-16.67%Miss-16.7%
    Jun 21
    		$0.11$0.10+10.00%Beat+22.2%
    Mar 21
    		$0.07$0.09-22.22%Miss-30.0%
    Dec 20
    		$0.11$0.09+22.22%Beat+37.5%
    Sep 20
    		$0.12$0.10+20.00%Beat-7.7%
    Jun 20
    		$0.09$0.09+0.00%Beat-10.0%
    Mar 20
    		$0.10$0.09+11.11%Beat+1100.0%
    Dec 19
    		$0.08$0.10-20.00%Miss+157.1%
    Sep 19
    		$0.13$0.12+8.33%Beat+262.5%
    Jun 19
    		$0.10$0.02+400.00%Beat+266.7%
    Mar 19
    		$-0.01N/A+92.31%Beat+83.3%
    Dec 18
    		$-0.14$-0.11-27.27%Miss-133.3%
    Sep 18
    		$-0.08$-0.08+0.00%Beat-60.0%
    Jun 18
    		$-0.06$-0.07+14.29%Beat-20.0%
    Mar 18
    		$-0.06$-0.06+0.00%Beat+0.0%
    Dec 17
    		$-0.06$-0.06+0.00%Beat-20.0%
    Sep 17
    		$-0.05$-0.06+16.67%Beat+0.0%
    Jun 17
    		$-0.05$-0.06+16.67%Beat-
    Mar 17
    		$-0.06$-0.06+0.00%Beat-
    Dec 16
    		$-0.05$-0.07+28.57%Beat-
    Sep 16
    		$-0.05$-0.07+28.57%Beat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$31.48
    SMA 20$31.45
    SMA 50$31.31
    SMA 200$25.47
    EMA 10$31.47
    EMA 20$31.42
    EMA 50$30.61
    EMA 200$26.67

    MACD

    Line: 0.14Signal: 0.19Hist: -0.05

    ADX

    ADX: 68.4+DI: 35.1-DI: 5.7

    Aroon & PSAR

    Aroon Up92.0
    Aroon DownN/A
    PSAR$31.47

    Bollinger Bands

    Upper Band$31.53
    Lower Band$31.37
    %B Position51%(Middle)
    Band Width0.74

    RSI (14-Day)

    Overbought
    70.2

    Momentum Oscillators

    Stoch %K85.6
    Stoch %D84.9
    Williams %R-15.8
    ROC (10d)0.2%
    Momentum0.05
    CCI (20d)83.0
    MFI (14d)68.4

    Volatility Measures

    ATR (14d)$0.07(0.2%)
    StdDev (20d)0.04
    Hist Vol1.4%(Low)

    Volume Flow

    VWAP$31.49
    OBV65.9M
    AD Line-12.2M
    CMF (20d)-0.063

    Volume Metrics

    Avg Vol (20d)2.6M
    Vol RatioN/A
    VWMA (20d)$31.46

    Pivot Points

    R3$31.49
    R2$31.49
    R1$31.49
    Pivot Point$31.49
    S1$31.49
    S2$31.49
    S3$31.49

    Advanced Oscillators

    TSI41.31
    Ultimate Osc40.7
    KST5.29

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$149.39M$152.61M$148.39M$146.56M$141.42M$141.82M$128.69M$122.71M$98.51M$110.57M$102.69M$99.58M
    Cost of Revenue$14.47M$26.07M$22.65M$20.61M$17.91M$21.64M$19.28M$15.40M$12.52M$15.81M$14.17M$12.04M
    Gross Profit$134.91M$126.54M$125.74M$125.95M$123.51M$120.18M$109.42M$107.31M$85.99M$94.76M$88.52M$87.54M
    Operating Expenses$61.68M$64.69M$59.47M$59.65M$60.14M$57.33M$58.51M$53.06M$58.86M$53.07M$125.71M$40.84M
    R&D$2.66M$1.81M$2.66M$4.36M$3.89M$3.80M$3.28M$2.98M$2.58M$1.97M$83.66M$3.95M
    SG&A$49.32M$53.42M$47.47M$45.95M$46.91M$44.19M$45.88M$40.73M$46.94M$42.04M$33.56M$28.40M
    Operating Income$73.23M$61.85M$66.27M$66.30M$63.37M$62.84M$50.91M$54.25M$27.13M$41.69M$-37,188,000$46.70M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$0$833,000$0
    Income Before Tax$84.23M$71.90M$71.03M$69.29M$71.29M$74.18M$57.20M$55.79M$29.09M$46.71M$-38,021,000$48.51M
    Income Tax Expense$20.50M$19.20M$18.25M$17.18M$14.55M$18.25M$13.32M$14.99M$5.81M$11.86M$-7,257,000$10.75M
    Net Income$63.73M$52.70M$52.78M$52.11M$56.74M$55.94M$43.88M$40.79M$23.27M$34.84M$-30,764,000$37.76M
    EBITDA$94.00M$81.44M$80.45M$78.75M$80.75M$83.64M$66.66M$65.22M$38.52M$55.85M$-29,453,000$57.08M
    EBIT$84.23M$71.90M$71.03M$69.29M$71.29M$74.18M$57.20M$55.79M$29.09M$46.71M$-38,021,000$48.51M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CPRX

    News

    Enterprise value to EBITDA forward of Catalyst Pharmaceuticals, Inc. – LS:A0LCUL

    This article displays the Enterprise Value to EBITDA forward for Catalyst Pharmaceuticals, Inc. (A0LCUL) on Lang & Schwarz Tradecenter. The page shows the current market status as closed with no trades recorded. It also outlines various financial and community data points available for the company.

    TradingView•7/30/26•
    Neutral

    Catalyst Pharmaceuticals Inc (CPRX) Earnings Forecast: Future EPS & Revenue Growth Estimates

    The article provides an earnings forecast for Catalyst Pharmaceuticals Inc (CPRX), noting its current earnings forecast score of 6.67, ranking 126th in the Pharmaceuticals industry. Analysts have an average price target of $34.00 for CPRX, with most recommending a "Buy" trend. The expected revenue for the next quarter is $156.31M, with an anticipated EPS of $0.48.

    TradingKey•7/29/26•
    Neutral

    Catalyst Pharmaceuticals Inc (CPRX) Income Statement

    This article provides a detailed income statement for Catalyst Pharmaceuticals Inc (CPRX), presenting quarterly and annual financial data spanning several fiscal years. It includes key financial metrics such as total revenue, cost of revenue, operating expenses, R&D expenses, operating profit, income before tax, net income, and earnings per share. The document also features an FAQ section to help users understand how to interpret the income statement and notable financial figures for fiscal year 2025.

    TradingKey•7/26/26•
    Somewhat-Bullish

    Catalyst Pharmaceuticals Inc (CPRX) Cash Flow

    This article provides a detailed cash flow statement for Catalyst Pharmaceuticals Inc (CPRX), including quarterly and annual data for operating, investing, and financing activities. It also defines key cash flow terms and offers insights into CPRX's financial performance, such as its operating cash flow, capital expenditures, and free cash flow for recent periods.

    TradingKey•7/26/26•
    Neutral

    Catalyst Pharmaceuticals, Inc. Revenue Breakdown – LS:A0LCUL

    The article provides a revenue breakdown for Catalyst Pharmaceuticals, Inc. (A0LCUL). Last year, the company generated 501.32 million EUR, with the Drug Products segment contributing 501.48 million EUR. The United States was the primary source of revenue, accounting for 501.48 million EUR.

    TradingView•7/26/26•
    Somewhat-Bullish

    Frequently Asked Questions About CPRX

    Does CPRX pay dividends?
    CPRX (CPRX) does not currently pay a regular dividend.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In